Post

New research · Rheumatology
Seminars in arthritis and rheumatism · 23h
ReviewSeminars in arthritis and rheumatism · 2026

Definition and prevalence of residual disease in inflammatory arthritis: a systematic literature review and meta-analysis.

Casper Webers, Marius L Smits, Ellen Renet … Astrid van Tubergen
Read paper
RheumatologyReview

Patient-reported indicators are frequently used to define residual disease.

Definition and prevalence of residual disease in inflammatory arthritis: a systematic literature review and meta-analysis.

Casper Webers et al. · Seminars in arthritis and rheumatism · 2026
Purpose

To assess how residual disease (i.e., clinically relevant signs/symptoms despite achieving treatment targets) is defined in rheumatoid arthritis (RA), psoriatic arthritis (PsA) or axial spondyloarthritis (axSpA), and estimate the prevalence/severity of residual disease in these diseases.

Methods

Systematic review of original research in RA/PsA/axSpA.

n = 84 studies
73%
Results
patient-reported symptoms were used more often to define ongoing symptoms
n = 84 studies
More results

Regarding residual disease definitions (59 studies), disease states were almost exclusively disease activity-based (>99%), but with much variation in specific instruments/thresholds.

Especially peripheral joint counts, pain, physical function and CRP were frequently used (42-56% of studies).

The prevalence of residual disease (84 studies) was notable.

More results

For example, 5-25% of RA and PsA patients in remission still had swollen joints, and up to one-third reported relevant pain or fatigue.

“
Conclusion · 1 of 2

Residual disease definitions in RA/PsA/axSpA are based on various disease activity instruments/thresholds and indicators (signs/symptoms). Residual disease affects up to half of patients.

Conclusion · 2 of 2

Future research should aim for a consensus-based definition of residual disease.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Case Report
creatinine at 6.28 mg/dL
high level of a waste product, indicating severe kidney damage
Study
80% (4/5)
Four out of five patients with refractory systemic lupus erythematosus achieved remission.
Study
AUC = 0.847
Good accuracy separating lupus patients from healthy people (higher AUC = better)
Cohort Study
2.8-fold
Current glucocorticoid dose contributes 2.8-fold more to all neuropsychiatric damage risk.
Cohort Study
HR 2.76 (95% CI: 1.25-6.10)
malnutrition is associated with a higher rate of death in people with systemic sclerosis
Guideline
102 recommendations
guidance for assessing, diagnosing, monitoring, and treating lupus
Cohort Study
0.633
arthritis patients taking JAK inhibitor drugs were less likely to develop new dry eye
Cohort Study
80% vs. 30%
placental blood-flow (vascular malperfusion) damage was far more common in these growth-restricted pregnancies